Harvey Bienenstock
Director/Board Member bei HAIVISION SYSTEMS INC.
Vermögen: - $ am 31.03.2024
Profil
Harvey Bienenstock is an Independent Director at Haivision Systems, Inc. since 2019 and Vice President-Finance at Haemosan, Inc. since 1993.
He was Vice President at IBEX Technologies, Inc. from 1982 to 1993 and Controller at First Quebec Corp.
from 1978 to 1982.
He completed his undergraduate and MBA degrees from McGill University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
HAIVISION SYSTEMS, INC.
-.--% | 18.01.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Harvey Bienenstock
| Unternehmen | Position | Beginn |
|---|---|---|
| HAIVISION SYSTEMS INC. | Director/Board Member | 01.04.2019 |
Haemosan, Inc.
 Haemosan, Inc. Regional BanksFinance Haemosan, Inc. operates as a bank holding company. The company was founded on August 20, 1979 and is headquartered in Mount-Royal, Canada. | Corporate Officer/Principal | 01.01.1993 |
Ehemalige bekannte Positionen von Harvey Bienenstock
| Unternehmen | Position | Ende |
|---|---|---|
| IBEX TECHNOLOGIES | Corporate Officer/Principal | 01.01.1993 |
| First Quebec Corp. | Comptroller/Controller/Auditor | 01.01.1982 |
Ausbildung von Harvey Bienenstock
| McGill University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| HAIVISION SYSTEMS INC. | Electronic Technology |
| Private Unternehmen | 3 |
|---|---|
IBEX Technologies, Inc.
 IBEX Technologies, Inc. Medical SpecialtiesHealth Technology IBEX Technologies, Inc. manufactures and markets enzymes for biomedical use. The firm also specializes in the custom aliquoting, filling, and lyophilization of enzymes in diagnostic disposables for medical devices. Its products include glycobiology enzymes from flavobacterium heparinum, collagen assays, collagen antibodies, and diamine oxidase liquid. The company was founded by Robert A. Heft on April 10, 1972 and is headquartered in Montréal, Canada. | Health Technology |
Haemosan, Inc.
Haemosan, Inc. Regional BanksFinance Haemosan, Inc. operates as a bank holding company. The company was founded on August 20, 1979 and is headquartered in Mount-Royal, Canada. | Finance |
| First Quebec Corp. |
